NO942781L - Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger - Google Patents

Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger

Info

Publication number
NO942781L
NO942781L NO942781A NO942781A NO942781L NO 942781 L NO942781 L NO 942781L NO 942781 A NO942781 A NO 942781A NO 942781 A NO942781 A NO 942781A NO 942781 L NO942781 L NO 942781L
Authority
NO
Norway
Prior art keywords
inactivating viral
bacterial blood
blood contaminants
inactivating
viral
Prior art date
Application number
NO942781A
Other languages
English (en)
Norwegian (no)
Other versions
NO942781D0 (no
Inventor
Jr Raymond P Goodrich
Nagendar Yerram
Roger W Hackett
Marjan Van Borssum Waalkes
Original Assignee
Cryopharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryopharm Corp filed Critical Cryopharm Corp
Publication of NO942781D0 publication Critical patent/NO942781D0/no
Publication of NO942781L publication Critical patent/NO942781L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
NO942781A 1992-01-27 1994-07-26 Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger NO942781L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82569192A 1992-01-27 1992-01-27
PCT/US1993/000401 WO1993014791A2 (en) 1992-01-27 1993-01-27 Method of inactivation of viral and bacterial blood contaminants

Publications (2)

Publication Number Publication Date
NO942781D0 NO942781D0 (no) 1994-07-26
NO942781L true NO942781L (no) 1994-09-15

Family

ID=25244689

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942781A NO942781L (no) 1992-01-27 1994-07-26 Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger

Country Status (10)

Country Link
EP (1) EP0633786B1 (de)
JP (1) JP2001509773A (de)
AT (1) ATE203679T1 (de)
AU (1) AU3476593A (de)
CA (1) CA2128866A1 (de)
DE (1) DE69330514T2 (de)
IL (1) IL104530A0 (de)
NO (1) NO942781L (de)
WO (1) WO1993014791A2 (de)
ZA (1) ZA93587B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
US5578486A (en) * 1994-08-05 1996-11-26 International Tlb Research Institute, Inc. Recombinant microbial fertilizer and methods for its production
AU691672B2 (en) * 1994-09-22 1998-05-21 Baxter International Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
WO1996036704A1 (en) * 1995-05-19 1996-11-21 New York Blood Center, Inc. Methods of use of phthalocyanines to inactivate blood borne parasites
AU710242B2 (en) * 1996-03-29 1999-09-16 Therakos, Inc. Photopheresis treatment of leukocytes
WO1997037536A1 (en) 1996-04-09 1997-10-16 Therakos, Inc. Method for removal of psoralens from biological fluids
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
DE59800935D1 (en) 1997-04-08 2001-08-02 Baxter Ag Immuntolerante prothrombinkomplex-präparation
WO1999002215A1 (en) * 1997-07-10 1999-01-21 Therakos, Inc. Treatment of inflammatory disorders of the bowel and urinary bladder
CN1203900C (zh) * 1998-01-06 2005-06-01 塞鲁斯公司 用于淬灭生物材料中病原体灭活剂的方法
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
WO2014194931A1 (en) 2013-06-03 2014-12-11 Onderzoeks- En Ontwikkelingsfonds Rode Kruis-Vlaanderen Pathogen reduction treatment
EP3172222A4 (de) 2014-07-24 2018-03-21 Washington University Gegen strahlungsinduzierte moleküle gerichtete zusammensetzungen und verfahren zur verwendung davon
WO2018148595A1 (en) 2017-02-10 2018-08-16 Washington University Antibodies to tip1 and methods of use thereof
WO2021074970A1 (ja) * 2019-10-15 2021-04-22 株式会社日立ハイテク 核酸試料処理装置および核酸試料処理方法
IL309030A (en) * 2021-06-14 2024-02-01 St Andrews Pharmaceutical Tech Ltd Apparatus for improving hydration and / or reducing particle size of a product and a method of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
SU959786A1 (ru) * 1980-04-17 1982-09-23 Московский технологический институт мясной и молочной промышленности Способ консервировани цельной крови
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
EP0124363B1 (de) * 1983-05-02 1990-12-19 Diamond Scientific Co. Photochemische Entkeimungsbehandlung von vollem Blut oder Blutbestandteilen
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
AU653337B2 (en) * 1990-04-16 1994-09-29 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
EP0544895B1 (de) * 1991-06-21 1997-08-27 Baxter International Inc. Verfahren zur inaktivierung von pathogenen in einer körperflüssigkeit

Also Published As

Publication number Publication date
ATE203679T1 (de) 2001-08-15
DE69330514D1 (de) 2001-09-06
JP2001509773A (ja) 2001-07-24
IL104530A0 (en) 1993-05-13
EP0633786A4 (de) 1995-04-19
EP0633786A1 (de) 1995-01-18
WO1993014791A3 (en) 2000-02-17
ZA93587B (en) 1994-07-07
DE69330514T2 (de) 2002-03-28
CA2128866A1 (en) 1993-08-05
AU3476593A (en) 1993-09-01
EP0633786B1 (de) 2001-08-01
WO1993014791A2 (en) 1993-08-05
NO942781D0 (no) 1994-07-26

Similar Documents

Publication Publication Date Title
NO942781L (no) Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger
IL97856A0 (en) Compositions containing cellular blood matter and method and processes for the inactivation of viral and bacterial blood components
ATE5371T1 (de) Kosmetische mittel.
NO894367L (no) System og fremgangsmaate for kvantitativ bestemmelse av konsentrasjonene av flere gasser i boreslam.
IT8747507A0 (it) Derivati di indolo, procedimenti per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
ES2039759T5 (es) Preparados estables, dispersables en agua fria.
ES8603950A1 (es) Un procedimiento para inactivar un virus asociado a un material biologico
FI854395L (fi) Sv40-expressionsvektor innehaollande hbxag-antigen som expressionsmarkering.
DK164157C (da) Trialkyl- eller arylsulf(ox)oniumphosphinat-derivater med fungicid aktivitet, fremgangsmaade til fremstilling deraf samt fungicid- og/eller baktericidpraeparater indeholdende de aktive forbindelser og en fremgangsmaade til sygdomsbehandling af plantevaekster
CA2056619A1 (en) Method of inactivation of viral and bacterial blood contaminants
DK254386D0 (da) Pyridinderivater, fremgangsmaade til fremstilling heraf og praeparaterindeholdende disse forbindelser
NO854217L (no) Fremgangsmaate for maaling og regulering av elektrokjemisk potensial og/eller komponentinnhold i behandlingsprosessen for verdifulle materialer.
DK490486A (da) Sammensaetning til behandling af atherosclerose, tromboser og/eller perifere karsygdomme
EA199900138A1 (ru) Обнаружение активности гепараназы млекопитающих и очистка гепараназы млекопитающих
ES2098377T3 (es) Reactivo de diagnostico anoxico estabilizado en solucion.
IT8747506A0 (it) Derivati di indolo ,procedimento per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
DE58904809D1 (de) Plasma-roentgenroehre, insbesondere zur roentgen-vorionisierung von gaslasern, und verwendung als elektronenkanone.
NO162241C (no) Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker.
FI853513A7 (fi) Saasteidenpoistoyksikkö työkaluja varten radioaktiivisten, kemiallisten ja biologisten saasteiden poistamiseksi niistä.
IT8584136A0 (it) Con buste di lavorazione in metodo ed apparecchiatura per laboratori fotografici. correlare pellicole fotografiche
IT7924779A0 (it) Impianto per la sterilizzazione di liquidi in genere mediante radiazioni ultraviolette e relativo procedimento.
DE3872628D1 (de) Makrozyklische liganden, an siliziumoxyd oder kieselgel gebunden, und deren verwendung zum selektiven und quantitativen entfernen und konzentrieren von in geringer konzentration gegenwaertigen ionen aus anderen ionen enthaltenden mischungen.
NO880835D0 (no) Fremgangsmaate og anordning for kvalitativ og/eller kvantitativ analyse av antigener, antistoffer, mikroorganismer eller andre celler.
HOWARD The role of oxygen in the repair process
DK164867C (da) Pyrimidooe4,5-gaaquinolin-derivater eller salte deraf og farmaceutiske formuleringer indeholdende disse